{"id":"W4405803075","doi":"10.1158/1078-0432.ccr-24-2729","title":"Challenges to Innovation Arising from Current Companion Diagnostic Regulations and Suggestions for Improvements","year":2024,"lang":"en","type":"editorial","venue":"Clinical Cancer Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Astellas Pharma; Regeneron Pharmaceuticals; International Association for the Study of Lung Cancer; Eisai; Daiichi Sankyo Europe; Sanofi; Genentech; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Flexibility (engineering); Companion diagnostic; Risk analysis (engineering); Diagnostic test; Quality (philosophy); Consistency (knowledge bases); Medicine; Clinical trial; Diagnostic accuracy; Unintended consequences; Medical physics; Precision medicine; New product development; Business; Computer science; Marketing; Pathology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02751996,0.002765453,0.002127541,0.00249322,0.003875159,0.01296275,0.00461739,0.02410888,0.008998567],"category_scores_gemma":[0.07220904,0.001015602,0.00236655,0.001459903,0.007501537,0.01372202,0.002616026,0.0380161,0.006447269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005000085,"about_ca_system_score_gemma":0.007407455,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001589181,"about_ca_topic_score_gemma":0.003640711,"domain_scores_codex":[0.9866088,0.002620998,0.001435834,0.001357118,0.007348355,0.0006289345],"domain_scores_gemma":[0.9152128,0.04832202,0.002981559,0.002244781,0.02430945,0.0069294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002468619,0.00001701924,0.00002255433,0.0002689298,0.0000137114,0.0001761303,0.00006517735,0.00007803795,0.00008852739,0.004969227,0.9806991,0.01357682],"study_design_scores_gemma":[0.0000261333,0.00002049289,0.00006491729,0.0003113567,0.00001931593,0.0002167334,0.0001039695,0.0001766581,0.00009321285,0.008313634,0.99063,0.00002368733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00006639211,0.01318785,0.0007873352,0.2002772,0.7827306,0.00002196347,0.00002728596,0.0001411848,0.002760252],"genre_scores_gemma":[0.001126479,0.01427105,0.001081274,0.1070791,0.8624329,0.00003987789,0.00002903487,0.00008192375,0.01385829],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.02751996,"threshold_uncertainty_score":0.1455412,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1617461595143211,"score_gpt":0.5629987054769863,"score_spread":0.4012525459626651,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}